Patent · US Active

Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease

US8058314B2 · kind B2 · utility

1Cited by
37References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 16, 2007
Grant dateNov 15, 2011
Priority date
Expiry dateJul 13, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/91102
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides the methodology and agents for treating any disease or clinical condition which is at least partly the result of endoplasmic reticulum-associated retention of proteins. Thus, the methods and agents of the present invention provide for the release of normally retained proteins from the endoplasmic reticulum. The present invention is particularly useful for treating any disease or clinical condition which is at least partly the result of endoplasmic reticulum-associated retention or degradation of mis-assembled or mis-folded proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.